LEADER 01474nam  2200469   450 
001 9910809225603321
005 20230803034024.0
010   $a1-909453-30-7
010   $a1-909453-31-5
035   $a(CKB)3430000000000041
035   $a(SSID)ssj0001599978
035   $a(PQKBManifestationID)16306846
035   $a(PQKBTitleCode)TC0001599978
035   $a(PQKBWorkID)14892612
035   $a(PQKB)11543360
035   $a(MiAaPQ)EBC5092513
035   $a(EXLCZ)993430000000000041
100   $a20171108h20132013  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aImportant considerations for clinical trial methodologies /$fVance Berger, Xiao Zhang, editors
210  1$aLondon, England :$cFuture Science Ltd,$d2013.
210  4$dİ2013
215   $a1 online resource (134 pages) $cillustrations (some color)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-909453-32-3 
320   $aIncludes bibliographical references at the end of each chapters and index.
606   $aClinical trials$xMethodology
615  0$aClinical trials$xMethodology.
676   $a615.19072
702   $aBerger$b Vance
702   $aZhang$b Xiao
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910809225603321
996   $aImportant considerations for clinical trial methodologies$93985392
997   $aUNINA